Institution
First Affiliated Hospital Zhejiang University
Also known as: Zheda Hospital · Zhejiang Provincial First Hospital
- 70running trials
- 41closed trials
- 35,974publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Enrolling by invitation
Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease
Not yet recruiting
Recruiting
Recruiting
Enrolling by invitation
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Recruiting
Enrolling by invitation
Enrolling by invitation
Recruiting
Recruiting
Recruiting
Recruiting
KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Recruiting
Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression
Recruiting
A Study to Evaluate the Safety, Tolerability and PK of SK-08
Not yet recruiting
The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease
Recruiting
Recruiting
Enrolling by invitation
Multicenter Prospective Cohort Study of Hypertriglyceridemia Acute Pancreatitis
Recruiting
Recruiting
Recruiting
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
Recruiting
Recruiting
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
Recruiting
Recruiting
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
Recruiting
Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease
Active, not recruiting
Recruiting
Recruiting
Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not
Active, not recruiting
Active, not recruiting
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Showing 50 of 70.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease7 recruiting
- Bipolar disorder4 recruiting
- Depression4 recruiting
- Lung cancer4 recruiting
- Acute myeloid leukaemia3 recruiting
- Fatty liver disease (MASLD/MASH)3 recruiting
- Multiple myeloma3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Childhood cancers2 recruiting
- Aortic aneurysm1 recruiting
- Brain aneurysm1 recruiting
- Bronchiectasis1 recruiting
- Cervical cancer1 recruiting
- Chronic kidney disease1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- COPD1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Fabry disease1 recruiting
- Kidney cancer1 recruiting
- Liver cirrhosis1 recruiting
- Mild cognitive impairment1 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
- Type 2 diabetes1 recruiting
- Vascular dementia1 recruiting
- Wilson disease1 recruiting
Closed trials
Completed
Completed
Completed
Completed
rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder
Terminated
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome
Completed
Completed
Completed
Completed
Completed
Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer
Completed
Terminated
Completed
Terminated
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
Completed
Completed
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
Registry name variants (19)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
The First Affiliated Hospital, Zhejiang University
Hangzhou, 310003
36 trials
The First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang 310003
28 trials
First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang 310020
21 trials
Department of Psychiatry, First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang 310000
4 trials
First affiliated hospital, Zhejiang University
Hangzhou, Zhejiang 310006
4 trials
The First Affiliated Hospital, Zhejiang University (Site 0109)
Hangzhou, Zhejiang 310006
3 trials
The First Affiliated Hospital Zhejiang University (Site 0106)
Hangzhou, Zhejiang 310003
2 trials
The First Affiliated Hospital Zhejiang University (Site 0136)
Hangzhou, Zhejiang 310003
2 trials
The First Affiliated Hospital of Zhejiang University (Site 0097)
Hangzhou, Zhejiang 310003
1 trial
The First Affiliated Hospital of Zhejiang University (Site 0804)
Hangzhou, Zhejiang 310003
1 trial
The First Affiliated Hospital of Zhejiang University (Site 2414)
Hangzhou, Zhejiang 310009
1 trial
The First Affiliated Hospital, Zhejiang University (Site 0025)
Hangzhou, Zhejiang 310003
1 trial
The First Affiliated Hospital, Zhejiang University (Site 0907)
Hangzhou, Zhejiang 310003
1 trial
The First Affiliated Hospital, Zhejiang University (Site 1211)
Hangzhou, Zhejiang 310003
1 trial
The First Affiliated Hospital.Zhejiang University (Site 2408)
Hangzhou, Zhejiang 310003
1 trial
The First Affiliated Hospital, Zhejiang University (Site 2826)
Hangzhou, Zhejiang 310002
1 trial
Contact: Study Coordinator
The First Affiliated Hospital, Zhejiang University (Site 3417)
Hangzhou, Zhejiang 310003
1 trial
The First Affiliated Hospital, Zhejiang University (Site 5404)
Hangzhou, Zhejiang 310000
1 trial
The First Affiliated Hospital, Zhejiang University (Site 6024)
Hangzhou, Zhejiang 310003
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Liver and biliary tract cancer202 works · 5 trials
- Lung cancer127 works · 22 trials
- Acute myeloid leukaemia48 works · 5 trials
- Gastric and oesophageal cancer44 works · 3 trials
- Pancreatic cancer43 works · 0 trials
- Fatty liver disease (MASLD/MASH)32 works · 3 trials
- Depression27 works · 4 trials
- Kidney cancer27 works · 3 trials
- Multiple myeloma26 works · 10 trials
- Diffuse large B-cell lymphoma24 works · 2 trials
- Acute lymphoblastic leukaemia24 works · 3 trials
- Bipolar disorder23 works · 7 trials
- Hepatitis B19 works · 0 trials
- Myelodysplastic syndromes15 works · 0 trials
- Myeloproliferative neoplasms15 works · 2 trials
- Thyroid cancer13 works · 1 trial
- Amyloidosis12 works · 2 trials
- Diabetic foot ulcer8 works · 0 trials
- IgA nephropathy7 works · 0 trials
- Liver cirrhosis6 works · 1 trial
- Female infertility5 works · 0 trials
- Vascular dementia5 works · 1 trial
- Thymoma and thymic carcinoma5 works · 0 trials
- Trigeminal neuralgia4 works · 0 trials
- Burkitt lymphoma4 works · 0 trials
Institution data: ROR 05m1p5x56 (CC0-1.0)Updated 15 Nov 2026